The DOI matches its Crossref record; 301 of the 302 references it cites were found in a registry or an index, and 1 are not checked yet.
Pneumococcal Capsules and Their Types: Past, Present, and Future
Open accessAbstract
SUMMARY: Streptococcus pneumoniae (the pneumococcus) is an important human pathogen. Its virulence is largely due to its polysaccharide capsule, which shields it from the host immune system, and because of this, the capsule has been extensively studied. Studies of the capsule led to the identification of DNA as the genetic material, identification of many different capsular serotypes, and identification of the serotype-specific nature of protection by adaptive immunity. Recent studies have led to the determination of capsular polysaccharide structures for many serotypes using advanced analytical technologies, complete elucidation of genetic basis for the capsular types, and the development of highly effective pneumococcal conjugate vaccines. Conjugate vaccine use has altered the serotype distribution by either serotype replacement or switching, and this has increased the need to serotype pneumococci. Due to great advances in molecular technologies and our understanding of the pneumococcal genome, molecular approaches have become powerful tools to predict pneumococcal serotypes. In addition, more-precise and -efficient serotyping methods that directly detect polysaccharide structures are emerging. These improvements in our capabilities will greatly enhance future investigations of pneumococcal epidemiology and diseases and the biology of colonization and innate immunity to pneumococcal capsules.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Home visits: a strategy to improve newborn survival - Authors' reply
(2008) · Americanae (AECID Library) · doi:10.1016/s0140 · Cited by 22,524
(1996) · Institutional Research Information System University of Turin (University of Turin) · doi:10.1111/j · Cited by 5,486
Immunobiology: the immune system in health and disease
(1995) · Choice Reviews Online · doi:10.5860/choice.32-3876 · Cited by 4,110
Journal of Biological Chemistry
(2021) · Journal of Biological Chemistry · doi:10.1074/jbc · Cited by 3,400
O'Brien, K. L., Wolfson, L. J., Watt, J. P., Henkle, E., Deloria-Knoll, M., McCall, N., Lee, E., Mulholland, K., Levine, O. S., & Cherian, T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61204-6 · Cited by 2,398
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
BLACK, S., SHINEFIELD, H., FIREMAN, B., LEWIS, E., RAY, P., HANSEN, J. R., ELVIN, L., ENSOR, K. M., HACKELL, J., SIBER, G., et al. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200003000-00003 · Cited by 2,293
IMMUNOBIOLOGY : the immunesystem in health and disease
Janeway, C. A. (1994) · Cited by 1,757
Morens, D. M., Taubenberger, J. K., & Fauci, A. S. (2008) · The Journal of Infectious Diseases · doi:10.1086/591708 · Cited by 1,625
Sexually Transmitted Diseases 7982 Treatment Guidelines
(1982) · American Pharmacy · doi:10.1016/s0160-3450(16)31823-2 · Cited by 1,573
The Significance of Pneumococcal Types
Griffith, F. (1928) · Journal of Hygiene · doi:10.1017/s0022172400031879 · Cited by 1,344
Research works printed but not linked: 6
- Bezançon F , Griffon V . 1897. Pouvoir agglutinatif du sérum dans les infections expérimentales et humaines à pneumocoques. II C R Soc Biol 49:579.
- Bezançon F , Griffon V . 1897. Pouvoir agglutinatif du sérum dans les infections expérimentales et humaines à pneumocoques. I C R Soc Biol 49:551.
- Eyre JWH , Washbourn JW . 1899. Further experiments with Pane's anti-pneumococcus serum. Br Med J 2:1247–1249.
- Neufeld F , Haendel L . 1910. Weitere untersuchungen uber pneumokokken-heilsera. III. Mitteilung Arbeiten aus dem Kaiserlichen Gesundheitsamte 34:293–304.
- Lister FS . 1913. Specific serological reactions with pneumococci from different sources. South African Institute for Medical Research.
- Makela PH , Butler JC . 2008. History of pneumococcal immunization, p 19–29. In Siber GR , Klugman KP , Makela PH (ed), Pneumococcal vaccines. ASM Press, Washington, DC.
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“The complexity and diversity of surface polysaccharides found on strains of a single bacterial species (>100 in the case of the pneumococcus) (843) might be explained not only by selection for evasion of the vertebrate antibody response (844), but also by the need to evade attack by environmental bacteriophages (843,…”
BackgroundPipkins, H. R., Bradshaw, J. L., Keller, L. E., Swiatlo, E., & McDaniel, L. S. (2017) · PLOS ONE · doi:10.1371/journal.pone.0179159 · Cited by 1,338
“Group I includes NESp that have a mutated, dysfunctional variant of the characteristic capsule polysaccharide biosynthetic (cps) locus, while group II includes NESp whose cps genes are replaced by novel genes that code for distinct pneumococcal proteins [6,7].”
BackgroundStreptococcus pneumoniae: transmission, colonization and invasion
Weiser, J. N., Ferreira, D. M., & Paton, J. C. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0001-8 · Cited by 1,098
Ganaie, F., Saad, J. S., McGee, L., van Tonder, A. J., Bentley, S. D., Lo, S. W., Gladstone, R. A., Turner, P., Keenan, J. D., Breiman, R. F., et al. (2020) · mBio · doi:10.1128/mbio.00937-20 · Cited by 464
“polyclonal serum (FS10d) and MAb Hyp10AG1, which targets Gal(1-6) created by wcrG”
BackgroundInfluentialSelf-citationBacterial biopolymers: from pathogenesis to advanced materials
Moradali, M. F., & Rehm, B. H. A. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0313-3 · Cited by 459
Metadata
- Authors
- Geno, K. A., Gilbert, G. L., Song, J. Y., Skovsted, I. C., Klugman, K. P., Jones, C., Konradsen, H. B., & Nahm, M. H.
- Affiliations
- University of Alabama at Birmingham (US)
- The University of Sydney (AU)
- Korea University Guro Hospital (KR)
- Statens Serum Institut (DK)
- Gates Foundation (US)
- National Institute for Biological Standards and Control (GB)
- ORCID
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2015-07
- Volume
- 28
- Issue
- 3
- Pages
- 871-899
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- PMC
- PMC4475641
- OpenAlex
- W1954112402
- Cited by
- 732
- References
- 291
- Citations by year
- 2026: 39 · 2025: 55 · 2024: 64 · 2023: 84 · 2022: 68 · 2021: 85 · 2020: 84 · 2019: 80 · 2018: 68 · 2017: 54 · 2016: 45 · 2015: 6
- FWCI
- 7.50
- Type
- journal article
- Language
- en
- Update notices
- correction (2020-12-23)
- Open access
- bronze
- doi.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Clinical Microbiology Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (HHSN272201200005C)
- National Heart, Lung, and Blood Institute (T32 HL07553, T32HL007553, T32HL105346)
- National Institute of Allergy and Infectious Diseases (R56AI031473, R56 AI-31473, HHSN272201200005C)
- Topics
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Life Sciences › Immunology and Microbiology › Microbiology › Microbial infections and disease research
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Keywords
- Streptococcus pneumoniae, capsular serotypes, serotyping, pneumococcal conjugate vaccine, serotype replacement, serotype switching, molecular serotyping, innate immunity, host immune evasion, pneumococcal epidemiology, pneumococcal carriage
- MeSH terms
- Bacterial Vaccines, Immunity, Innate, Polysaccharides, Bacterial, Streptococcus pneumoniae, Bacterial Capsules, Genome, Bacterial, Serogroup
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pneumococcal Capsules and Their Types: Past, Present, and Future. https://app.cochat.ai/papers/10.1128/cmr.00024-15
- The paper
- Geno, K. A., Gilbert, G. L., Song, J. Y., Skovsted, I. C., Klugman, K. P., Jones, C., Konradsen, H. B., & Nahm, M. H. (2015). Pneumococcal Capsules and Their Types: Past, Present, and Future. Clinical Microbiology Reviews. https://doi.org/10.1128/cmr.00024-15
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.